307
with intraoperative use of Carnoy’s solution. Histopathological
examination of the specimen confirmed it as KCOT. Currently,
the patient was put under strict periodical follow-ups. As of six
months follow-up, no sign of recurrence noted clinically and radio-
logically. Surgeons should be aware of such atypical presentation
of KCOT to avoid misdiagnosis.
http://dx.doi.org/10.1016/j.ijom.2017.02.1032Odontogenic myxoma: report of three cases
S. Konchanthes
∗
, C. Chinkrua, W. Chatupos, T. Khamchai
Department of Oral and Maxillofacial Surgery, Chiang Mai,
Thailand
Background:
Odontogenic myxoma (OM) represents an uncom-
mon benign odontogenic tumour of the jaw bone with locally
aggressive behaviour. Most reports show a slight predilection for
females. It is a slow growing tumour consisting of an accumulation
of mucoid ground substance with little collagen. Radiographic fea-
tures are always lucent, although the pattern may be quite variable.
It may appear as a well-circumscribed or diffuse lesion.
Objectives:
To report three cases of odontogenic myxoma. Clin-
ical findings and radiological features along with diagnostic and
treatment were review.
Methods:
Three cases of odontogenic myxoma, age ranged from
10 to 42 years, were diagnosed and underwent surgical treatment
at the Faculty of Dentistry, Chiang Mai University between 2013
and 2015. Biographic profiles, clinical manifestations, radiologi-
cal features and surgical treatment of each case were analysed.
Findings:
Most of patients presented with a non-tender, bony hard
swelling of jawbone. Radiograph showed unilocular radiolucency
in two cases and multilocular radiolucency (tennis racquet strings
appearance) in one case. All cases wunderwent bone resection.
No clinical or radiological signs of recurrence have been found
until now.
Conclusions:
Surgical treatment of odontogenic myxoma varies
from simple enucleation and curettage to bony resection. We
discuss the important factors that must be considered when deter-
mining the proper management approach to odontogenicmyxoma.
Long-term follow up examination should be performed.
http://dx.doi.org/10.1016/j.ijom.2017.02.1033Chronic recurrent mandibular osteomyelitis consistent with
SAPHO syndrome: a case report
P. Kumplanont
Institute of Dentistry, Suranaree University of Technology,
Nakornrachasrima, Thailand
Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO)
syndrome is a rare condition of nonsuppurative osteomyelitis.
Its name is an acronym for various osteoarticular and dermato-
logical manifestations that can appear in the same patient. Its
diagnosis is based onmedical history, clinical symptoms, imaging,
histopathology, and scintigraphy bone scan that show inflamma-
tion of bone with neither abscess nor sequestrum. Appropriate
treatment cannot be concluded.
An eight-year-old boy consistent with SAPHO syndrome
presented. He had an underlying disease of beta Thalassemia,
haemoglobin type E. He first presented with two-month painless,
hyperostotic mandibular swelling, with later intermittent painful
swelling of the surrounding soft tissue and third degree mobil-
ity of the anterior teeth. Severe trismus was also appeared later.
There was neither pus or chronic fistula nor any sequestration.
Radiograph showed ill-defined mixed radiolucent and radiopaque
of expanded mandible, no root resorption. Scintigraphy bone
scan showed two active osteomyelitis foci: mandible and finger
bone. Histopathological examination showed nonspecific acute
and chronic inflammation of bone and soft tissue with the diagno-
sis of nonsuppurative osteomyelitis. The patient was treated with
various modalities including antibiotics (Augmentin, penicillin),
non-steroidal anti-inflammatory drugs (NSAIDs; Ibuprofen),
and decortications. These treatments seemed to provide some
improvement but not cure, particularly NSAIDs. Improvement of
inflammation, trismus and bone swelling was seen after the child
was growing.
After a long-term of 10-year follow-up, the patient had
symptom-free with underdeveloped mandible caused by previous
trismus. The patient is still in the follow-up appointments. Steps
of diagnosis and treatment strategies of this interesting case are
presented.
http://dx.doi.org/10.1016/j.ijom.2017.02.1034Comparative study of metronidazole and clarithromycin in
the treatment of severe chronic periodontitis
C.X. Li
∗
, Z.C. Gong, Z.Q. Lin, H. Liu
Department of Oral and Maxillofacial Oncology Surgery,
Stomatological Medical Center, The First Affiliated Hospital of
Xinjiang Medical University, China
Objective:
To compare the clinical efficacy of metronidazole and
clarithromycin in the treatment of severe chronic periodontitis,
provides the evidence and reference for the clinical therapy.
Methods:
112 severe chronic periodontitis patients were enrolled
to conduct oral clarithromycin treatment after stomatological con-
ventional basic therapy, which is the observation group (OG),
in our hospital from September 2015 to the present. Retrospec-
tive analysis between the observation group and the control group
(CG), the patients who were given oral metronidazole treatment
after stomatological conventional basic therapy, is chosen to com-
pare their prognostic indicators three months after treatment such
as sulcus bleeding index (SBI), probing depth (PD), attachment
level (AL), and the inflammatory factors in gingival fluid of 7 days
before and after treatment, which include interleukin-1 (IL-1),
tumour necrosis factor- (TNF- ).
Results:
There was no significant difference in SBI, PD, AL, IL-1,
and TNF- between the two groups (
P
> 0.05) before the treat-
ment, but they had comparability. After the treatment, they all had
declined than before, especially the PD and AL of OG were lower
than CG (
P
< 0.05). Meanwhile, seven days after the therapy, IL-1
and TNF- of OG were lower than CG too (
P
< 0.05).
Conclusion:
The curative effect of clarithromycin in the treatment
of patients with severe chronic periodontitis is better than that of
metronidazole. Accordingly, the clarithromycin therapy is worthy
of promotion and extension.
http://dx.doi.org/10.1016/j.ijom.2017.02.1035




